How does ADVATx work?
ADVATx uses high powered, 589nm wavelength yellow light, which is widely acknowledged as the gold standard in treating various vascular conditions, and 1319nm wavelength to stimulate collagen production and to improve skin texture and overall dermal health. Treatments with ADVATx are comfortable, with side effects usually only limited to mild swelling and redness. Significant changes in the skin can occur with each treatment.
What does it treat?
ADVATx utilizes two different wavelengths to treat various skin conditions:
589nmwavelength to treat:
- Telangiectasias – face
- Poikiloderma of Civatte
- Acne Vulgaris
- Stretch marks
- Venous lake
I have had multiple treatments before with IPL, BBL, and Excel V for redness on my face, neck, and chest. I think the AdvaTx is far superior to the others. My skin looks better than it did ten years ago!
1319nm wavelength to treat:
- Fine Lines and Wrinkles
- Atrophic Acne Scars
- Mild/Moderate Inflammatory Acne
ADVATx for Acne:
For the first time, physicians can now address active acne and acne scarring with a single device. ADVATx is the only laser in the world to combine a 1319nm wavelength to address overactive sebaceous glands with a 589nmwavelength to target P.acnes bacteria and the underlying vasculature which supports cystic nodules. Furthermore, the 589nm wavelength helps remove the redness in both active acne and acne scars, leading to visible, long term results.
What to expect from an ADVATx treatment:
Does the treatment hurt?
There is little to no discomfort.
How much down time?
You will experience mild redness and perhaps a little swelling for 2—4 hours.
What do I do after treatment?
A minimum of 24 hours is recommended before direct sun exposure. It is imperative that you apply a sunscreen SPF 30 or higher daily.
When will I see results?
With most vascular treatments you will see a change within the first 24 hours, but multiple treatments are required for optimal results. Acne and scar treatments require multiple treatments for optimal results.